Human Papillomavirus (HPV) is a common sexually transmitted infection that affects both males and females. Traditionally, the focus of HPV vaccination has been on females due to the virus’s association with cervical cancer. However, HPV also poses significant health risks to males, making vaccination crucial for everyone.
HPV is a group of more than 200 related viruses. It is transmitted through intimate skin-to-skin contact, often during sexual activity. While many HPV infections resolve on their own without causing health problems, some strains can lead to serious conditions such as genital warts, and cancers of the throat, penis, and anus.
The Centre for Disease Control and Prevention (CDC) recommends routine HPV vaccination for boys at ages 11 or 12, but the vaccine can be given as early as age 9 and up to age 26. For those who missed the initial vaccination window, catch-up vaccines are advised up to age 26. In some cases, vaccination might be recommended for males aged 27-45 based on their health conditions and risk factors.